Overview
Miri Adler practices practicing medicine in Jerusalem, Israel.
Her clinical expertise encompasses Squamous Cell Lung Carcinoma and Nonalcoholic Steatohepatitis (NASH).
She is actively involved in clinical research, co-authoring 19 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Miri Adler
Is Miri Adler a top-rated expert for Squamous Cell Lung Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Miri Adler is classified as an Experienced expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Miri Adler participate in research or clinical trials?
Yes. Miri Adler has published 19 articles and abstracts on conditions like Squamous Cell Lung Carcinoma. You can view a list of Miri Adler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Nonalcoholic Steatohepatitis (NASH)Ms. Adler isExperienced. Learn about Nonalcoholic Steatohepatitis (NASH).
- Squamous Cell Lung CarcinomaMs. Adler isExperienced. Learn about Squamous Cell Lung Carcinoma.